Lithos Group Ltd
OTC:LITSD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (29.4), the stock would be worth $-6.5 (10 097% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.3 | $0.07 |
0%
|
| Industry Average | 29.4 | $-6.5 |
-10 097%
|
| Country Average | 14.5 | $-3.2 |
-5 017%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
Lithos Group Ltd
OTC:LITSD
|
5.3m USD | -0.3 | -0.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
98.3B USD | 14.1 | 55.6 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.3B EUR | 9.9 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.9B USD | 0 | 12.2 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.4B EUR | 14.3 | 19.1 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.2B EUR | 16.9 | 23.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.6B USD | 16.5 | 22.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.5B USD | 17.8 | 25.6 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.1B EUR | 9.9 | 11.2 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.8B USD | -28.2 | -28.4 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 9.7 | 13.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10.6 |
| Median | 14.5 |
| 70th Percentile | 20.6 |
| Max | 3 794.4 |
Other Multiples
Lithos Group Ltd
Glance View
Lithos Group Ltd. is a mining technology company, which engages in the exploration of minerals in Canada. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-07-28. The firm offers AcQUA, which is a patent-pending technology that spans the complete value chain from the conditioning and pre-treatment of raw brines through the direct lithium extraction (DLE) phase into the polishing and purification of battery grade lithium feedstock. The firm has two processing facilities: a 4,000 square feet (sq ft) lab in Denver, Colorado and a 55,000 sq ft complex in Bessemer, Alabama. The firm is engaged in a contract with multiple strategic mineral resource owners and processing brines from the Salars in Chile and Argentina, and the Smackover reservoir in the Southeastern United States. The Company’s wholly owned subsidiary is Aqueous Resources LLC.
